OrbiMed Capital GP IV LLC
CIK 1502240 · last filed 2024-07-02
OrbiMed Capital GP IV LLC is a corporate insider who has filed 30 SEC Form 4 insider transactions across 9 companies since 2010. The most recent filing shows the insider sold $4.0M of TELA on Jul 2, 2024. Across all open-market trades the lifetime net is −$678.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $13.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$13.48M
9
30
-$678.12M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TELA | 10%+ Owner | 5,485,084 | $0.86 | $4.72M | $5.96M | 2 | 2024-07-02 |
| ALEC | 10%+ Owner | 1,921,804 | $1.53 | $2.94M | -$244.48M | 7 | 2020-04-16 |
| Principia Biopharma Inc. (PRNB) Delisted | 10%+ Owner | 1,605,713 | — | — | -$52.00M | 2 | 2019-05-22 |
| BOLD | 10%+ Owner | 4,129,638 | $1.41 | $5.82M | -$56.95M | 1 | 2017-09-29 |
| Relypsa Inc (RLYP) Delisted | 10%+ Owner | 7,664,171 | — | — | -$233.05M | 6 | 2015-12-23 |
| OTONOMY, INC. (OTIC) Delisted | Director | 2,245,300 | $0.08 | $172.9K | -$11.88M | 1 | 2015-11-19 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Director | 1,120,609 | $19.00 | $21.29M | -$84.48M | 5 | 2015-07-21 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | 10%+ Owner | 1,267,000 | $58.70 | $74.37M | $6.00M | 1 | 2015-02-05 |
| Anthera Pharmaceuticals Inc (ANTH) Delisted | Director | 7,462,000 | — | — | -$7.23M | 5 | 2013-02-01 |
Recent Filings
30 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-07-02 | TELA | Sell (S) | −856,600 | -$4.04M | EDGAR |
| 2020-04-16 | ALEC | Sell (S) | −170,828 | -$4.02M | EDGAR |
| 2020-04-09 | ALEC | Sell (S) | −759,770 | -$18.04M | EDGAR |
| 2020-04-02 | ALEC | Sell (S) | −500,000 | -$12.25M | EDGAR |
| 2020-03-25 | ALEC | Sell (S) | −277,306 | -$6.85M | EDGAR |
| 2020-03-04 | ALEC | Sell (S) | −5,622,609 | -$146.19M | EDGAR |
| 2020-01-13 | ALEC | Sell (S) | −1,139,991 | -$22.23M | EDGAR |
| 2019-11-13 | TELA | Mixed | +3,687,060 | $10.00M | EDGAR |
| 2019-08-09 | ALEC | Sell (S) | −1,950,000 | -$34.91M | EDGAR |
| 2019-05-22 | Principia Biopharma Inc. (PRNB) Delisted | Sell (S) | −2,000,000 | -$60.50M | EDGAR |